The Efficacy of Co-Treatment with Suberoylanilide Hydroxamic Acid and Mitomycin C on Corneal Scarring after Therapeutic Keratectomy: An Animal Study

References

• Gimbel HV, Penno EE, van Westenbrugge JA, Ferensowicz M, Furlong MT. Incidence and management of intraoperative and early postoperative complications in 1000 consecutive laser in situ keratomileusis cases. Ophthalmology 1998;105:1839–1847
   PubMed Web of Science ®Google Scholar
• Rajan MS, Jaycock P, O’Brart D, Nystrom HH, Marshall J. A long term study of photorefractive keratectomy; 12-year follow-up. Ophthalmology 2004;111:1813–1824
   PubMed Web of Science ®Google Scholar
• Camellin M. Laser epithelial keratomileusis with mitomycin C: indications and limits. J Refract Surg 2004;20:693–698
   Google Scholar
• Thornton I, Xu M, Krueger RR. Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia. J Refract Surg 2008;24:68–76
   PubMed Web of Science ®Google Scholar
• Varela JC, Goldstein MH, Baker HV, Schultz GS. Microarray analysis of gene expression patterns during healing of rat corneas after excimer laser photorefractive keratectomy. Invest Ophthalmol Vis Sci 2002;43:1772–1782
   PubMedGoogle Scholar
• Netto MV, Mohan RR, Sinha S, Sharma A, Gupta PC, Wilson SE. Effect of prophylactic and therpeutic mitomycin C on corneal apoptosis, proliferation, haze, and keratocyte density. J Refract Surg 2006;22:562–574
   PubMed Web of Science ®Google Scholar
• Gambato C, Ghirlando A, Moretto E, Busato F, Midena E. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology 2005;112:208–218
   PubMed Web of Science ®Google Scholar
• Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 1996;15:537–540
   PubMed Web of Science ®Google Scholar
• Safianik B, Ben-Zion I, Garzozi HJ. Serious corneoscleral complications after pterygium excision with mitomycin C. Br J Ophthalmol 2002;86:357–358
   PubMedGoogle Scholar
• Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992;99:1647–1654
   PubMed Web of Science ®Google Scholar
• Wu KY, Hong SJ, Huang HT, Lin CP, Chen CW. Toxic effects of mitomycin-C on cultured corneal keratocytes and endothelial cells. J Ocul Pharmacol Ther 1999;15:401–411
   PubMedGoogle Scholar
• Saika S. TGF-beta signal transduction in corneal wound healing as a therapeutic target. Cornea 2004;23:S25–S30
   PubMedGoogle Scholar
• Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isono M, et al. SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J Biol Chem 2007;282:151–158
   PubMed Web of Science ®Google Scholar
• Iizuka M, Smith MM. Functional consequences of histone modifications. Curr Opin Genet Dev 2003;13:154–160
   PubMed Web of Science ®Google Scholar
• Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW, et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 2001;7:437–443
   PubMed Web of Science ®Google Scholar
• Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000;92:1210–1216
   PubMed Web of Science ®Google Scholar
• Frederic B, Celine C. Histone deacetylase inhibitors: new drugs for the treatment of inflammatory disease? Drug Discov Today 2005;10:202–203
   Google Scholar
• Kim TH, Kim SW, Woo JM, Rho JH, Lee DJ, Park JM, et al. Co-treatment of suberolyanilide hydroxamic acid and mitomycin-C induces the apoptosis of rabbit tenon's capsule fibroblast and improves the outcome of glaucoma filtration surgery. Curr Eye Res 2008;33:237–245
   PubMed Web of Science ®Google Scholar
• Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: molecular mechanism of action. Oncogene 2007;26:5541–5552
   PubMed Web of Science ®Google Scholar
• Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA, et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci USA 1998;95:3003–3007
   PubMed Web of Science ®Google Scholar
• Cohen LA, Amin S, Marks PA, Rifkind RA, Desai D, Richon VM. Chemoprevention of carcinogen induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA). Anticancer Res 1999;19:4999–5005
   PubMed Web of Science ®Google Scholar
• Fantes FE, Hanna KD, Waring GO, Pouliquen Y, Thompson KP, Savoldelli M. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol 1990;108:665–675
   PubMed Web of Science ®Google Scholar
• Kosaka M, Nishina Y, Takeda M, Matsumoto K, Nishimune Y. Reversible effects of sodium butyrate on the differentiation of F9 embryonal carcinoma cells. Exp Cell Res 1991;192:46–51
   PubMedGoogle Scholar
• Roh MS, Kim CW, Park BS, Kim GC, Jeong JH, Kwon HC, et al. Trichostatin A induces apoptosis on human osteosarcoma cells in histone acetylation- and mitochondria-dependent fashions. Apoptosis 2004;9:583–589
   PubMed Web of Science ®Google Scholar
• Kong X, Lin Z, Liang D, Fath D, Sang N, Caro J. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1 alpha. Mol Cell Biol 2006;26:2019–2028
   PubMed Web of Science ®Google Scholar
• Niki T, Rombouts K, De Bleser P, De Smet K, Rogiers V, Schuppan D, et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology 1999;29:858–867
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Mori Y, Dowling E, Varga J. Trichostatin A blocks TGF-β induced collagen gene expression in skin fibroblasts: involvement of Sp1. Biochem Biophys Res Commun 2007;354:420–426
   PubMed Web of Science ®Google Scholar
• Glenisson W, Castronovo V, Waltregny D. Histone deacetylase 4 is required for TGF-β induced myofibroblastic differentiation. BioChim Biophys Acta 2007;1773:1572–1582
   PubMed Web of Science ®Google Scholar
• Yoshida M, Beppu T. Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. Exp Cell Res 1988;177:122–131
   PubMed Web of Science ®Google Scholar
• Zou Q, Wang Y, Yang L, Wang Y, Chen P, Wang Y, et al. Histone deacetylase inhibitors blocked activation and caused senescence of corneal stromal cells. Mol Vis 2008;14:2556–2565
   PubMedGoogle Scholar
• Mohan RR, Liang Q, Kim WJ, Helena MC, Baerveldt F, Wilson SE. Apoptosis in the cornea: further characterization of Fas-Fas ligand system. Exp Eye Res 1997;65:575–589
   PubMed Web of Science ®Google Scholar
• Jester JV, Huang J, Petroll WM, Cavanagh HD. TGF-β induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGF-β, PDGF and integrin signaling. Exp Eye Res 2002;75:645–657
   PubMed Web of Science ®Google Scholar
• Wilson SE, He YG, Weng J, Li Q, McDowall AW, Vital M, et al. Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp Eye Res 1996;62:325–328
   PubMed Web of Science ®Google Scholar
• Zhang HY, Gharaee-Kermani M, Phan SH. Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1 beta. Immunol 1997;158:1392–1399
   Google Scholar
• Zhang HY, Phan SH. Inhibition of myofibroblast apoptosis by transforming growth factor β-1. Am J Respir Cell Mol Biol 1999;21:658–665
   PubMed Web of Science ®Google Scholar
• Shephard P, Martin G, Smola-Hess S, Brunner G, Krieg T, Smola H. Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am J Pathol 2004;164:2055–2066
   PubMed Web of Science ®Google Scholar
• Werner S, Krieg T, Smola H. Keratinocyte–fibroblast interactions in wound healing. J Invest Dermatol 2007;127:998–1008
   PubMed Web of Science ®Google Scholar
• Harmeet K, Shyam SC, Vandana A, Chikako S, Steven EW. Corneal myofibroblast viability: opposing effects of IL-1 and TGF-β1. Exp Eye Res 2009;89:152–158
   PubMedGoogle Scholar